Description
About Exemptia:
Exemptia, manufactured by Zydus, is a leading biologic medication indicated for the treatment of various autoimmune diseases, including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, psoriasis, Crohn’s disease, and ulcerative colitis. The active ingredient in Exemptia is Adalimumab, a tumor necrosis factor (TNF) inhibitor that works by targeting and neutralizing excess TNF-alpha in the body, which plays a key role in the inflammatory processes underlying these conditions.
Key Features:
- Powerful Biologic Therapy: Exemptia offers potent therapeutic effects by targeting the underlying inflammatory pathways associated with autoimmune diseases.
- Adalimumab Composition: Each pre-filled syringe of Exemptia contains 40 mg of Adalimumab, ensuring precise dosing and consistent therapeutic outcomes.
- TNF Inhibitor Mechanism: Adalimumab binds to and neutralizes TNF-alpha, a pro-inflammatory cytokine, thereby reducing inflammation and alleviating symptoms associated with autoimmune diseases.
- Manufactured by Zydus: Exemptia is manufactured by Zydus, a reputable pharmaceutical company known for its high-quality medications and commitment to patient care.
- Clinically Proven Efficacy: The efficacy and safety of Exemptia have been established through extensive clinical trials, making it a trusted treatment option for patients and healthcare providers.
- Convenient Pre-Filled Syringe Formulation: Exemptia is formulated as a pre-filled syringe, offering patients a convenient and user-friendly mode of administration for self-injection.
Indications:
Exemptia (Adalimumab) is indicated for the treatment of:
- Rheumatoid arthritis
- Psoriatic arthritis
- Ankylosing spondylitis
- Psoriasis
- Crohn’s disease
- Ulcerative colitis
Usage Directions:
Exemptia should be administered under the supervision of a qualified healthcare professional experienced in the use of biologic therapies. The recommended dosage and frequency of administration may vary depending on the specific autoimmune disease being treated and the individual patient’s response to therapy. Patients should receive proper training on self-injection techniques if they are to administer Exemptia at home.
Storage Information:
- Store Exemptia pre-filled syringes in the original packaging in a refrigerator at a temperature of 2°C to 8°C.
- Do not freeze.
- Protect from light.
- Keep out of reach of children.
Caution:
- Exemptia should not be used in patients with active infections or tuberculosis.
- Serious infections, including tuberculosis and fungal infections, have been reported with the use of TNF inhibitors like Adalimumab.
- Patients should be monitored closely for signs of infection during Exemptia therapy.
Disclaimer:
The information provided herein is for informational purposes only and should not be construed as medical advice or a substitute for professional medical consultation. Patients should consult their healthcare providers regarding diagnosis, treatment, and potential side effects associated with Exemptia therapy.
Reviews
There are no reviews yet.